Breakthrough in Wound Care: MolecuLightDX Earns FDA MDDT Status - AktieGo MolecuLight announced that its MolecuLightDX® wound measurement system has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). This program valid...

MolecuLightDX® just got FDA MDDT qualification — one of only 20 tools ever.

Researchers can now use it as a regulatory-grade biomarker in wound care trials. aktiego.com/breakthrough...

#MedTech #FDA #WoundCare #MolecuLight #Investing #aktiego #ClinicalTechTakeover #BreakthroughOrBeLeftBehind